methylprednisolone has been researched along with Cancer of Pituitary in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ajduk, J; Košec, A; Kruljac, I | 1 |
| Dhoot, M; Kanakpur, S; Katti, V; Ramamurthy, LB; Shet, SD | 1 |
| Akahane, C; Ikeda, S; Takei, Y | 1 |
| Bierke, P; Broomé-Karlsson, A; Haraldsson, I; Nilsson, A | 1 |
| Comey, CH; Girkin, CA; Goodman, ML; Kline, LB; Lunsford, LD | 1 |
| Glaser, JS; Job, OM; Schatz, NJ | 1 |
| Caselitz, J; Saeger, W | 1 |
| Glaser, JS; Schatz, NJ; Zimmerman, CF | 1 |
8 other study(ies) available for methylprednisolone and Cancer of Pituitary
| Article | Year |
|---|---|
Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma.
Topics: Adult; Audiometry, Pure-Tone; Bromocriptine; Cochlear Diseases; Diuretics; Furosemide; Glucocorticoids; Hearing Loss, Sensorineural; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Pituitary Neoplasms; Prolactinoma; Recurrence | 2019 |
Neuro-ophthalmic presentation of COVID-19 disease: A case report.
Topics: Adenoma; COVID-19; COVID-19 Drug Treatment; Eye Infections, Viral; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; SARS-CoV-2 | 2021 |
Osmotic demyelination syndrome: reversible MRI findings in bilateral cortical lesions.
Topics: Adenoma; Aged; Brain Diseases; Glucocorticoids; Humans; Hyponatremia; Hypophysectomy; Hypopituitarism; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelinolysis, Central Pontine; Pituitary Neoplasms; Pulse Therapy, Drug; Remission Induction; Sodium Chloride | 2003 |
Induction of pituitary tumours by combination of oestrogenic hormones and 90Sr.
Topics: Adenoma, Acidophil; Adenoma, Chromophobe; Animals; Estradiol; Estrogens; Hyperplasia; Male; Methylprednisolone; Mice; Mice, Inbred CBA; Neoplasms, Experimental; Organophosphorus Compounds; Pituitary Gland; Pituitary Neoplasms; Strontium Radioisotopes | 1980 |
Radiation optic neuropathy after stereotactic radiosurgery.
Topics: Adenoma; Adult; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Methylprednisolone; Middle Aged; Optic Nerve; Optic Nerve Diseases; Pituitary Neoplasms; Prednisone; Radiosurgery; Vision Disorders; Visual Fields | 1997 |
Spontaneous resolution of pituitary adenoma after apoplexy.
Topics: Adenoma; Fludrocortisone; Humans; Hydrocortisone; Hypopituitarism; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; Remission, Spontaneous; Thyroxine | 2000 |
The ultrastructure of the pituitary gland under chronic stimulation of the ACTH-cells in human pathology and animal experiments.
Topics: Adenoma; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Cushing Syndrome; Humans; Hyperplasia; Lypressin; Male; Methylprednisolone; Pituitary Gland; Pituitary Neoplasms; Rats | 1979 |
Magnetic resonance imaging of radiation optic neuropathy.
Topics: Adenoma; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Nasopharyngeal Neoplasms; Optic Nerve; Optic Nerve Diseases; Pituitary Neoplasms; Radiation Injuries; Sella Turcica; Skull Neoplasms | 1990 |